FDA Issues Interim Final Rule for Reporting Adverse Events on Human Drug Labels

Summary

The FDA is issuing an interim final rule requiring the addition of a toll-free number on the labeling of certain human drug products, which can be used to report side effects, and advises that the number is not intended for medical advice.